Governance and ethical business supported by Green IT (SDG 17)

The digitalization of the pharmaceutical industry, including companies like STADA, has substantially expanded its potential for sustainable development.

Advancements in Information Technology (IT) have opened new avenues like data analytics, artificial intelligence, and machine learning, enabling pharmaceutical companies to refine their processes, enhance productivity, and reduce waste. These technologies help streamline supply chain management, minimize environmental footprint, and contribute to more efficient use of resources, thus aligning with the principles of sustainable development.

As a case in point, STADA, with its commitment to innovation and improvement, has leveraged digital tools to bolster its manufacturing and distribution processes. By harnessing the power of IT in the pursuit of its sustainability goals, STADA showcases how digital advancements in pharma can both optimize operational efficiency and affirm a commitment to environmental and societal stewardship.  

Only in 2022, by switching to Microsoft Azure Cloud solutions, STADA saved 99.58%[1] of its carbon emissions, compared to other offline or cloud equivalent solution. 

[1] Based on the data provided form Microsoft software’s reporting deck.